This session provides a clinical practice update regarding the pathophysiology, diagnosis, management and advanced therapy considerations for cardio-oncology. This session will review the risk factors, cancer therapies that promote cardiomyopathy, and management factors associated with cardio-oncology.

At the completion of this educational activity, the learner will be able to:
1. Recognize the shared risk factors between cancer and heart failure.
2. Assess the cardiac risks of the newer cancer therapies (including targeted therapies, immunotherapies, CAR-T cell therapies).
3. Recommend early detection methods for heart failure related to cancer therapies using novel diagnostic modalities and their clinical application.
4. Review outcomes and management of heart failure related to cancer therapies including advanced heart failure therapies.

In support of improving patient care, the Heart Failure Society of America is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The Heart Failure Society of America designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™.  Successful completion of this CME activity, which includes participation in the evaluation component and post-test with 75% passing score, enables the participant to earn up to 1.5 MOC contact hours in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program.  Learners should claim only the credit commensurate with the extent of their participation in the activity.

 This educational activity is approved for nursing continuing professional development (NCPD) units by the Heart Failure Society of America, an accredited provider of the American Nurses Credentialing Center. This activity is approved for a maximum 1.5 contact hours. Learners should claim only the credit commensurate with the extent of their participation in the activity.

The Heart Failure Society of America is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education (CPE). This event is accredited for up to 1.5 contact hours of knowledge-based CPE.

ACPE Universal Activity Numbers (UAN): JA4008267-0000-22-005-H04-P